Skip to main content
David Iberri, MD, Oncology, Stanford, CA

David Joseph Iberri MD


Medicine Resident, Stanford Hospital & Clinics

Join to View Full Profile
  • 300 Pasteur Dr# StanfordStanford, CA 94305

  • Phone+1 650-498-4560

Dr. Iberri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2013 - 2016
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2013
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2010 - 2011
  • University of Vermont College of Medicine
    University of Vermont College of MedicineClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2026
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses
    David Iberri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Evaluating Selinexor in Patients with Relapsed/Refractory DLBCL
    Evaluating Selinexor in Patients with Relapsed/Refractory DLBCLSeptember 1st, 2020
  • Has the FDA Been Approving Some Drugs Without Proper Evidence?
    Has the FDA Been Approving Some Drugs Without Proper Evidence?August 20th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: